Both in Food & Tobacco
Arcadia Biosciences vs 22nd Century Group
Over the past year RKDA returned −93.8% and XXII returned −100.0%; their daily moves had a correlation of 0.12.
RKDA −93.8% XXII −100.0%Growth of $1, one year, split-adjusted
| Metric | RKDA | XXII |
|---|---|---|
| Price | $0.2220 | $1.30 |
| Market cap | $534.8K | $716.1K |
| Today | −6.64% | −16.67% |
| 1 month | +10.4% | −96.6% |
| 6 months | −79.3% | −99.8% |
| Year to date | −88.8% | −100.0% |
| 1 year | −93.9% | −100.0% |
| Revenue growth (YoY) | −0.8% | −29.9% |
| Gross margin | 43.7% | 43.4% |
| Net margin | −434.2% | −759.8% |
| P/E (TTM) | — | — |
| Price / sales | 0.1× | 0.0× |
| Net cash | $4.2M | $5.0M |
| Dividend yield | — | — |
| Volatility (60d) | 128.9% | 1,220.7% |
| Short % of float | 4.8% | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).